image
Healthcare - Biotechnology - NASDAQ - US
$ 0.35
4.48 %
$ 57.1 M
Market Cap
None
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one QSIAW stock under the worst case scenario is HIDDEN Compared to the current market price of 0.35 USD, Quantum-Si incorporated is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one QSIAW stock under the base case scenario is HIDDEN Compared to the current market price of 0.35 USD, Quantum-Si incorporated is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one QSIAW stock under the best case scenario is HIDDEN Compared to the current market price of 0.35 USD, Quantum-Si incorporated is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart QSIAW

image
$2.5$2.5$2.0$2.0$1.5$1.5$1.0$1.0$0.5$0.5$0.0$0.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
3.06 M REVENUE
182.62%
-109 M OPERATING INCOME
2.33%
-101 M NET INCOME
-5.26%
-87.8 M OPERATING CASH FLOW
6.64%
-32.7 M INVESTING CASH FLOW
-22.78%
35.9 M FINANCING CASH FLOW
23977.85%
1.19 M REVENUE
51.46%
-30.7 M OPERATING INCOME
-9.22%
-33.1 M NET INCOME
-30.85%
-22.9 M OPERATING CASH FLOW
1.17%
-5.92 M INVESTING CASH FLOW
-100.94%
35.8 M FINANCING CASH FLOW
1789600.00%
Balance Sheet Quantum-Si incorporated
image
Current Assets 218 M
Cash & Short-Term Investments 210 M
Receivables 1.33 M
Other Current Assets 7.07 M
Non-Current Assets 29.9 M
Long-Term Investments 0
PP&E 29.1 M
Other Non-Current Assets 808 K
84.56 %2.85 %11.72 %Total Assets$247.9m
Current Liabilities 18.2 M
Accounts Payable 1.93 M
Short-Term Debt 3.7 M
Other Current Liabilities 12.6 M
Non-Current Liabilities 14.3 M
Long-Term Debt 9.25 M
Other Non-Current Liabilities 5.01 M
5.95 %11.40 %38.70 %28.50 %15.45 %Total Liabilities$32.5m
EFFICIENCY
Earnings Waterfall Quantum-Si incorporated
image
Revenue 3.06 M
Cost Of Revenue 1.46 M
Gross Profit 1.6 M
Operating Expenses 110 M
Operating Income -109 M
Other Expenses -7.57 M
Net Income -101 M
20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)3m(1m)2m(110m)(109m)8m(101m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
52.32% GROSS MARGIN
52.32%
-3550.56% OPERATING MARGIN
-3550.56%
-3303.04% NET MARGIN
-3303.04%
-46.89% ROE
-46.89%
-40.75% ROA
-40.75%
-46.55% ROIC
-46.55%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Quantum-Si incorporated
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)202020202021202120222022202320232024202420252025
Net Income -101 M
Depreciation & Amortization 4.6 M
Capital Expenditures -4.58 M
Stock-Based Compensation 8.89 M
Change in Working Capital 0
Others -275 K
Free Cash Flow -92.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Quantum-Si incorporated
image
QSIAW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Quantum-Si incorporated
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
8. Profile Summary

Quantum-Si incorporated QSIAW

image
COUNTRY US
INDUSTRY Biotechnology
MARKET CAP $ 57.1 M
Dividend Yield 0.00%
Description Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.
Contact 29 Business Park Drive, Branford, DE, 06405 https://www.quantum-si.com
IPO Date None
Employees 149
Officers Mr. Jeffrey Alan Hawkins President, Chief Executive Officer & Director Mr. Jeffry R. Keyes CPA Chief Financial Officer & Treasurer Dr. Christian Lapointe J.D., Ph.D. General Counsel & Corporate Secretary Ms. Lindsay Thompson Chief Human Resources Officer Ms. Katherine Atkinson Senior Vice President of Demand Generation & Corporate Brand Mr. Todd C. Bennett Chief Commercial Officer Dr. Jonathan M. Rothberg Ph.D. Founder & Executive Director Mr. Todd Rearick Chief Technology Officer Dr. John S. Vieceli Ph.D. Chief Product Officer